AIM
ALAB icon

AXA Investment Managers’s Astera Labs ALAB Stock Holding History

AXA Investment Managers’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$33.6M Buy
+171,587
New +$28.2M 0.09% 200

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

AXA Investment Managers's ALAB Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Astera Labs (ALAB) in Q3 2025: 171,587 shares worth $33.6M. The stake represents 0.09% of the portfolio and ranks #200 among its holdings.

657 funds tracked by Wall St. Rank hold ALAB as of Q3 2025.

  • AXA Investment Managers held 171,587 shares of Astera Labs worth $33.6M as of Q3 2025.
  • Astera Labs was a new AXA Investment Managers position in Q3 2025.
  • Astera Labs made up 0.09% of AXA Investment Managers's portfolio in Q3 2025, its #200 holding.
  • 657 funds tracked by Wall St. Rank held Astera Labs as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.